[BRUSSELS] Japanese drugmaker Takeda Pharmaceutical is set to win conditional EU antitrust approval for its US$62-billion bid for London's Shire, the biggest ever overseas acquisition by a...

<p/> [LONDON] For Christophe Weber, the boss of Japan's Takeda Pharmaceutical, securing a US$62 billion deal last week to buy drugmaker Shire at the fifth time of asking was the easy bit...

[LONDON] The London stock market opened firmer on Tuesday following a UK public holiday, with the benchmark FTSE 100 index gaining 0.1 per cent to 7,573.15 points.

<p/> [HONG KONG] Takeda Pharmaceutical Co is nearing an agreement to buy rival drugmaker Shire Plc, people familiar with the matter said, in what would mark the biggest ever takeover by the...

[TOKYO] The board of Irish pharmaceutical company Shire will recommend a new £46 billion (S$84.7 billion) takeover bid by Japanese firm Takeda to its shareholders, it said in a statement released...

[LONDON] Takeda Pharmaceutical Co sweetened its offer for drugmaker Shire Plc to more than US$60 billion after three prior bids were rejected, wooing investors in the US company with a higher cash...

TAKEDA Pharmaceutical Co Ltd said that its annual profit will outstrip a prior estimate and reach a six-year high, boosted by stronger sales of the cancer drug Velcade, after earlier reporting better...